Latest Posts
REOPENING & RECOVERING: Aspects of disaster recovery from the COVID-19 shutdown
By David Schmiege I have had countless conference calls with clients over the past 8-10 weeks as practices contemplate the necessary steps to reopen their vein practices and regain their momentum. The COVID-19 pandemic is wreaking havoc on our economy. As with many small businesses, the pandemic has had
IVC 2020 CANCELLED
The 18th Annual International Vein Congress, scheduled for July 9-11 at the Loews Miami Beach Hotel in collaboration with the Society for Vascular Surgery, has been cancelled. “ I just cancelled IVC today,” Jose I. Almeida, MD, FACS, told Vein Therapy News May 21. “We’ll be doing some video and
THE TSA HOARDED 1.3 MILLION N95 MASKS EVEN THOUGH AIRPORTS ARE EMPTY AND IT DOESN’T NEED THEM
new graph TSA officials stockpiled a huge shipment of N95 masks they knew they didn’t need even after two agency officials asked to donate them. Airport traffic fell 95 percent, and the masks have sat unused as hospitals searched desperately for them. By J. David McSwane
GENERAL RADIOLOGIST MOSTLY WORK AS MULTISPECIALISTS
By Erik L. Ridley General radiologists in the U.S. mostly work as multispecialists with specific areas of subspecialty focus, and nearly all have at least one of these subspecialty focus areas, according to research from the Harvey L. Neiman Health Policy . To assess the individual work efforts of radiologists,
REMDESIVIR: GILEAD IS DONATING ITS SUPPLY, BUT WHAT’S A FAIR PRICE?
How much should Gilead Sciences charge for its now-authorized COVID-19 therapy remdesivir? Up to $4,460 per patient, an influential pricing watchdog figures. While Gilead has yet to present a marketing plan for the first coronavirus treatment to have shown clinical benefits in a well-designed randomized study, the Institute for Clinical and